Summary
RPG Life Sciences plans to invest Rs 500 crore over the next 12 months to enhance its manufacturing and API capabilities through strategic acquisitions. The company has committed Rs 700 crore for expansion and aims for Rs 2,000-2,500 crore revenue by 2030.